In 2011 this blog was listed as one of the top 10 blog in pharma technical information it is popular amongst the pharmacists and pharma industry professionals. We have published very important and very useful information for pharma industry professionals.

Friday, April 28, 2023

New drug and first treatment and a drug for scorpion sting exclusively now available.

First specific treatment for scorpion stings is approved by US FDA, gets approval as an orphan drug.

The US FDA has now approved a new treatment for scorpion sting , a new treatment comprising of immunoglobulin against scorpion sting, name of product approved is Anascorp (Equine) Injection, it is approved as an orphan drug and its a first drug exclusively approved for Centruroides scorpions sting.

Drug is an immunoglobuline G (Ig G) prepared by sensitizing horse with scorpion venom and collecting  horse serum and digesting it with pepsin an enzyme which can digests protein,  followed by separation F(ab’)2 fragments by process of fractionation to get  immunoglobulin F(ab’)2 fragments to take care of anaphylaxis associated with horse serum which are further purified to remove any viral contaminants and lyophilized, it is a polyvalent sterile non pyrogenic preparation.( also see What is PEGylation technology )

How the drug act against scorpion sting:
Drug Anascorp contains specific immunoglobuline G (Ig G) or antibodies against scorpion venom, when it is injected intravenously in to patient who got a scorpion sting , the drug binds with scorpion venom in the blood and tissue in patient , this bound venom is then eliminated out of body easily by further protecting patients tissue and body from bad effects of scorpion sting.

Scorpion sting if left in treated may become life threatening in some patients , typically it causes breathing problem, blurred vision, muscular twitching and uncoordinated muscle movements, fluid in lungs, increased salivation, indistinct speech, difficulty in swallowing and abnormal eye movement.
The clinical study was conducted at various parts in Arizona in united states (multicenter clinical trial) where

Clinical trial : Efficacy and safety of Anascorp was evaluated in multicenter open lable blinded clinical trial across Arizona.

Most common side effect of the drug is nousia , vomiting ,pyrexia and rash.
Precautions while using Anascorp (Equine) Injection include : known anaphylaxix to horse serum, serum sickness, myalgias .

Drug is manufactured by Instituto Bioclon, S.A. de C.V., of Tlalpan, Mexico, D.F.and licenced to Rare Disease Therapeutics Inc., Franklin, TN, and distributed by Accredo Health Group Inc., Memphis, TN.

You may also like

No comments:


What is 21 CFR Part 11, US FDA guidelines requirements of FDA compliance and CFR 21 Part 11.

What is a Site Master file of a pharmaceutical company

What is Generic Drug

What is Reference Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents

What are Post Market studies

Why a drug is bound to protein, What is protein binding?  What is drug absorption , distribution ?

Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic Resistance and Antibiotic resistance mechanism

Antioxidants food supplements

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Clean Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials

PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?

US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA

REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates